These results largely support the previously reported hypothesis that a relative decrease in subcutaneous to visceral adipose tissue mass is related to e.g. insulin resistance, dyslipidemia and lower adiponectin levels1. The gene discussed is ADIPOQ; the disease is metabolic syndrome.